Regional office - North America
295 Madison Avenue
18th Floor, New York
NY10017 United States
Tel: +1 646 653 7026
listed companiesSee more
Companies with HQs in usaSee more
Pharmaceutical & healthcare | 09/11/2018
Sunesis released its abstracts for the upcoming American Society of Hematology (ASH) meeting, which included an update on the company’s ongoing Phase Ib/II trial of vecabrutinib in hematologic cancers. The study is still in the dosing portion of the trial on the 50mg arm, but the data to date showed a safety and tolerability profile in line with expectations. The company will provide a complete update of the trial progress at ASH.
Mining | 09/11/2018
On 29 October, Endeavour (EDV) announced a maiden resource at its Fetekro property in north central Côte d’Ivoire of 719koz Au, contained within 9.8Mt. The resource equates to 4.0% of Endeavour’s prior, global resource (on a 100% basis), or 4.8% on an attributable basis. However, it equates to a rather more significant 4.5-7.6% of Endeavour’s 9.5-16.0Moz exploration target over the course of the next five years. Moreover, at 2.25g/t, its average grade is 21.0% above the average…
Investment Companies | 09/11/2018
Martin Currie Asia Unconstrained Trust (MCP) aims to deliver growth in line with nominal Asia ex-Japan GDP on a rolling three-year basis. It follows a detailed, bottom-up approach to investing in a concentrated portfolio of 20–30 of Asia’s highest-quality and most sustainable businesses, unconstrained by a benchmark. Although market conditions have become more challenging for Asian equities, MCP’s manager Andrew Graham believes the portfolio’s high-quality companies are poised…
Pharmaceutical & healthcare | 07/11/2018
Pluristem ended FY18 with an operating loss of $33.7m mostly attributed to R&D expenditure ($22.6m) and as of 30 June 2018 had $30.6m in net cash. The company recently announced its plans to present at several November conferences, including top-line data from its Phase II intermittent claudication (IC) study at the American Heart Association (AHA) Scientific Sessions, as well as an overview of its cell therapy products in clinical development at BioEurope.
Investment Companies | 06/11/2018
BioPharma Credit (BPCR) provides access to a diverse portfolio of debt instruments for life science companies, consisting mainly of senior secured loans at present. Structural changes in the industry and high M&A activity constitute positive drivers of BPCR’s new debt investments. Despite increased life sciences equity and convertible bonds issues, the trust has invested c US$640m so far this year (and has outstanding commitments of US$140.5–160.5m). The trust has recently completed…
Edison North America
Edison’s North American office opened in 2011 to provide research services to companies listed on North American stock exchanges. Companies of all sizes benefit from our research service, which provides the highest standards of equity research and unrivalled distribution of our reports on a global and unrestricted basis.